Productivity Losses Due to Migraine in Slovenia: An Analysis of Absenteeism and Presenteeism Costs Based on Administrative and Self-Reported Data

1Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population - burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71(8):559–66. doi: 10.1212/01.wnl.0000323925.29520.e7.BigalMESerranoDReedMLiptonRBChronic migraine in the population - burden, diagnosis, and satisfaction with treatmentNeurology20087185596610.1212/01.wnl.0000323925.29520.e7Open DOISearch in Google Scholar

2Stovner LJ et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:954–76. doi: 10.1016/S1474-4422(18)30322-3.StovnerLJGlobal, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016Lancet Neurol2018179547610.1016/S1474-4422(18)30322-3Open DOISearch in Google Scholar

3Zaletel-Kragelj L, Zaletel M, Eržen I. Ocena prevalence glavobola v splošni populaciji odraslih prebivalcev Slovenije glede na izbrane dejavnike. In: Žvan B, Zaletel M, Zupan M, editors. Migrena 2018: zbornik poglavij strokovnega srečanja in učbenik za zdravnike, zdravstvene delavce in študente Medicinske in Zdravstvene fakultete. Ljubljana: Društvo za preprečevanje možganskih in žilnih bolezni, 2018: 27–40.Zaletel-KrageljLZaletelMErženIOcena prevalence glavobola v splošni populaciji odraslih prebivalcev Slovenije glede na izbrane dejavnikeIn:ŽvanBZaletelMZupanMeditors.Migrena 2018: zbornik poglavij strokovnega srečanja in učbenik za zdravnike, zdravstvene delavce in študente Medicinske in Zdravstvene fakulteteLjubljanaDruštvo za preprečevanje možganskih in žilnih bolezni20182740Search in Google Scholar

4Byford S, Torgerson D J, Raftery J. Economic note: cost of illness studies. BMJ. 2000;320(7245):1335. doi: 10.1136/bmj.320.7245.1335.ByfordSTorgersonD JRafteryJEconomic note: cost of illness studiesBMJ20003207245133510.1136/bmj.320.7245.1335112732010807635Open DOISearch in Google Scholar

5Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327–37. doi: 10.3350/cmh.2014.20.4.327.JoCCost-of-illness studies: concepts, scopes, and methodsClin Mol Hepatol20142043273710.3350/cmh.2014.20.4.327427806225548737Open DOISearch in Google Scholar

6Ferrari MD. The economic burden of migraine to society. Pharmacoeconomics. 1998;13(6):667–76. doi: 10.2165/00019053-199813060-00003.FerrariMDThe economic burden of migraine to societyPharmacoeconomics19981366677610.2165/00019053-199813060-0000310179702Open DOISearch in Google Scholar

7Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics. 1992;2(1):67–76. doi: 10.2165/00019053-199202010-00008OsterhausJTGuttermanDLPlachetkaJRHealthcare resource and lost labour costs of migraine headache in the USPharmacoeconomics199221677610.2165/00019053-199202010-0000810146980Open DOISearch in Google Scholar

8Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(10):718–79. doi: 10.1016/j.euroneuro.2011.08.008.GustavssonASvenssonMJacobiFAllgulanderCAlonsoJBeghiECost of disorders of the brain in Europe 2010Eur Neuropsychopharmacol201121107187910.1016/j.euroneuro.2011.08.00821924589Open DOISearch in Google Scholar

9Badia X, Magaz S, Gutierres L, Galvan J. The burden of migraine in Spain: beyond direct costs. Pharmacoeconomics. 2004;22(9):591–603. doi: 10.2165/00019053-200422090-00004.BadiaXMagazSGutierresLGalvanJThe burden of migraine in Spain: beyond direct costsPharmacoeconomics200422959160310.2165/00019053-200422090-0000415209528Open DOISearch in Google Scholar

10Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barre J, Katsarava Z, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012;19(5):703–11. doi: 10.1111/j.1468-1331.2011.03612.x.LindeMGustavssonAStovnerLJSteinerTJBarreJKatsaravaZThe cost of headache disorders in Europe: the Eurolight projectEur J Neurol20121957031110.1111/j.1468-1331.2011.03612.x22136117Open DOISearch in Google Scholar

11Berg J. Economic evidence in migraine and other headaches: a review. Eur J Health Econ. 2004;5(Suppl I):43–54. doi: 10.1007/s10198-005-0288-z.BergJEconomic evidence in migraine and other headaches: a reviewEur J Health Econ20045Suppl I435410.1007/s10198-005-0288-z15754073Open DOISearch in Google Scholar

12Bigal ME, Moraes FA, Fernandes LC, Bordini CA, Speciali JG. Indirect costs of migraine in a public Brazilian hospital. Headache. 2001;41(5):503–8. doi: 10.1046/j.1526-4610.2001.01089.x.BigalMEMoraesFAFernandesLCBordiniCASpecialiJGIndirect costs of migraine in a public Brazilian hospitalHeadache2001415503810.1046/j.1526-4610.2001.01089.xOpen DOISearch in Google Scholar

13Clarke CE, MacMillan L, Sondhi S, Wells NE. Economic and social impact of migraine. QJM. 1996;89(1):77–84. doi: 10.1093/oxfordjournals.qjmed.a030141.ClarkeCEMacMillanLSondhiSWellsNEEconomic and social impact of migraineQJM1996891778410.1093/oxfordjournals.qjmed.a030141Open DOISearch in Google Scholar

14Allen D, Hines EW, Pazdernik V, Konecny LT, Breitenbach E. Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study. Hum Resour Health. 2018;16(1):59. doi: 10.1186/s12960-018-0321-9.AllenDHinesEWPazdernikVKonecnyLTBreitenbachEFour-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence studyHum Resour Health20181615910.1186/s12960-018-0321-9Open DOISearch in Google Scholar

15Vodušek DB, Kos M, Dolenc VV, Tomori M, Neubauer D, Sobocki P. Cost of disorders of the brain in Slovenia. Zdrav Vestn. 2008;77(Suppl II):5–11.VodušekDBKosMDolencVVTomoriMNeubauerDSobockiPCost of disorders of the brain in SloveniaZdrav Vestn200877Suppl II511Search in Google Scholar

16Bon J, Koritnik B, Bresjanac M, Repovs G, Pregelj P, Dobnik B, et al. Cost of disorders of the brain in Slovenia in 2010. Zdrav Vestn. 2013;82(3):164–75. Accessed May 31st, 2019 at: https://vestnik.szd.si/index.php/ZdravVest/article/view/724.BonJKoritnikBBresjanacMRepovsGPregeljPDobnikBCost of disorders of the brain in Slovenia in 2010Zdrav Vestn201382316475Accessed May 31st, 2019 at: https://vestnik.szd.si/index.php/ZdravVest/article/view/724.Search in Google Scholar

17Becker G. Human capital. 3rd ed. Chicago: Chicago University Press, 1993.BeckerGHuman capital3rd ed.ChicagoChicago University Press199310.7208/chicago/9780226041223.001.0001Search in Google Scholar

18SURS. SI-STAT database. Structure of earnings statistics – annual data. Accessed April 1st, 2019 at: https://pxweb.stat.si/pxweb/Database/Demographics/07_labour_force/10_earnings_costs/03_07113_structure_stats/03_07113_structure_stats.aspSURS. SI-STAT databaseStructure of earnings statistics – annual dataAccessed April 1st, 2019 at: https://pxweb.stat.si/pxweb/Database/Demographics/07_labour_force/10_earnings_costs/03_07113_structure_stats/03_07113_structure_stats.aspSearch in Google Scholar

19Stewart WF, Roy J, Lipton RB. Migraine prevalence, socioeconomic status, and social causation. Neurology. 2013;81(11):948–55. doi: 10.1212/WNL.0b013e3182a43b32.StewartWFRoyJLiptonRBMigraine prevalence, socioeconomic status, and social causationNeurology201381119485510.1212/WNL.0b013e3182a43b32Open DOISearch in Google Scholar

20Zaletel M, Keček-Plešec K, Pegam A, Žvan B. Prevalenca glavobola in migrene v slovenski delovno aktivni populaciji ter njun vpliv na produktivnost. In: Žvan B, Zaletel M, Zupan M, editors. Akutna možganska kap XII. Ljubljana: Društvo za preprečevanje možganskih in žilnih bolezni, 2018:177–86.ZaletelMKeček-PlešecKPegamAŽvanBPrevalenca glavobola in migrene v slovenski delovno aktivni populaciji ter njun vpliv na produktivnostIn:ŽvanBZaletelMZupanMeditors.Akutna možganska kap XIILjubljanaDruštvo za preprečevanje možganskih in žilnih bolezni201817786Search in Google Scholar

21Žvan B, Zaletel M, Pogačnik T. Slovenske smernice za obravnavo migrene 2006. Ljubljana: Društvo za preprečevanje možganskih in žilnih bolezni, 2006.ŽvanBZaletelMPogačnikTSlovenske smernice za obravnavo migrene 2006LjubljanaDruštvo za preprečevanje možganskih in žilnih bolezni2006Search in Google Scholar

22Ospina MB, Dennett L, Waye A, Jacobs P, Thompson AH. A systematic review of measurement properties of instruments assessing presenteeism. Am J Manag Care. 2015 1;21(2):e171–85.OspinaMBDennettLWayeAJacobsPThompsonAHA systematic review of measurement properties of instruments assessing presenteeismAm J Manag Care20151212e17185Search in Google Scholar

23van Roijen L, Essink-Bot ML, Koopmanschap MA, Michel BC, Rutten FFH. Societal perspective on the burden of migraine in The Netherlands. Pharmacoeconomics. 1995;7(2):170–9. doi: 10.2165/00019053-199507020-00008.van RoijenLEssink-BotMLKoopmanschapMAMichelBCRuttenFFHSocietal perspective on the burden of migraine in The NetherlandsPharmacoeconomics199572170910.2165/00019053-199507020-00008Open DOISearch in Google Scholar

24Groot W, Maassen van den Brink H. A direct method for estimating the compensating income variation for severe headache and migraine. Soc Sci Med. 2004;58(2):305–14. doi: 10.1016/S0277-9536(03)00208-9.GrootWMaassen van den BrinkHA direct method for estimating the compensating income variation for severe headache and migraineSoc Sci Med20045823051410.1016/S0277-9536(03)00208-9Open DOISearch in Google Scholar

25Noben CYG, Evers SMAA, Nijhuis FJ, de Rijk AE. Quality appraisal of generic self-reported instruments measuring health-related productivity changes: a systematic review. BMC Public Health. 2014;4(14):115. doi: 10.1186/1471-2458-14-115.NobenCYGEversSMAANijhuisFJde RijkAEQuality appraisal of generic self-reported instruments measuring health-related productivity changes: a systematic reviewBMC Public Health201441411510.1186/1471-2458-14-115394227124495301Open DOISearch in Google Scholar

26Ospina MB, Dennett L, Waye A, Jacobs P, Thompson AH. A systematic review of easurement properties of instruments assessing presenteeism. Am J Manag Care. 2015;21(2): e171–85. doi: 10.2165/00019053-199813060-00003.OspinaMBDennettLWayeAJacobsPThompsonAHA systematic review of easurement properties of instruments assessing presenteeismAm J Manag Care2015212e1718510.2165/00019053-199813060-0000310179702Open DOISearch in Google Scholar

27Loeppke R, Hymel PA, Lofland JH, Pizzi LT, Konicki DL, Anstadt GW, et al. Health-related workplace productivity measurement: general and migraine-specific recommendations from the ACOEM expert panel. J Occup Environ Med. 2003;45(4):349–59. doi: 10.1097/01.jom.0000063619.37065.e2.LoeppkeRHymelPALoflandJHPizziLTKonickiDLAnstadtGWHealth-related workplace productivity measurement: general and migraine-specific recommendations from the ACOEM expert panelJ Occup Environ Med20034543495910.1097/01.jom.0000063619.37065.e212708138Open DOISearch in Google Scholar

28Lipton RB, Gandhi SK, Fitzgerald T, Yeung PP, Cohen JM, Yang R, et al. The positive impact of fremanezumab on work productivity and activity impairment in patients with chronic migraine. Neurology. 2018;90(Suppl 15):32.007. Accessed May 31st, 2019 at: https://n.neurology.org/content/90/15_Supplement/S32.007.LiptonRBGandhiSKFitzgeraldTYeungPPCohenJMYangRThe positive impact of fremanezumab on work productivity and activity impairment in patients with chronic migraineNeurology201890Suppl 1532.007. Accessed May 31st, 2019 at: https://n.neurology.org/content/90/15_Supplement/S32.007.Search in Google Scholar

29Steiner TJ, Lipton RB. The Headache-Attributed Lost Time (HALT) Indices: measures of burden for clinical management and population-based research. J Headache Pain. 2018;19(1):12. doi: 10.1186/s10194-018-0837-3.SteinerTJLiptonRBThe Headache-Attributed Lost Time (HALT) Indices: measures of burden for clinical management and population-based researchJ Headache Pain20181911210.1186/s10194-018-0837-3579695529396646Open DOISearch in Google Scholar

30Lublóy Á. Economic burden of migraine in Latvia and Lithuania: direct and indirect costs. BMC Public Health. 2019;19:1242. doi: 10.1186/s12889-019-7461-2.LublóyÁEconomic burden of migraine in Latvia and Lithuania: direct and indirect costsBMC Public Health201919124210.1186/s12889-019-7461-2673425531500616Open DOISearch in Google Scholar

31D’Amico D, Sansone E, Grazzi L, Giovannetti AM, Leonardi M, Schiavolin S, et al. Multimorbidity in patients with chronic migraine and medication overuse headache. Acta Neurol Scand. 2018;138(6):515–522. doi: 10.1111/ane.13014.D’AmicoDSansoneEGrazziLGiovannettiAMLeonardiMSchiavolinSMultimorbidity in patients with chronic migraine and medication overuse headacheActa Neurol Scand2018138651552210.1111/ane.1301430107027Open DOISearch in Google Scholar

32Rammohan K, Mundayadan SM, Das S, Shaji CV. Migraine and mood disorders: prevalence, clinical correlations and disability. J Neurosci Rural Pract. 2019;10(1):28–33. doi: 10.4103/jnrp.jnrp_146_18.RammohanKMundayadanSMDasSShajiCVMigraine and mood disorders: prevalence, clinical correlations and disabilityJ Neurosci Rural Pract2019101283310.4103/jnrp.jnrp_146_18633798430765967Open DOISearch in Google Scholar

33Fishman P, Black L. Indirect costs of migraine in a managed care population. Cephalalgia. 1999;19(1):50–7. doi: 10.1046/j.1468-2982.1999.1901050.x.FishmanPBlackLIndirect costs of migraine in a managed care populationCephalalgia199919150710.1046/j.1468-2982.1999.1901050.xOpen DOISearch in Google Scholar